Amarin (AMRN) vs CAMP4 Therapeutics (CAMP)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
CAMP4 Therapeutics (CAMP) has outperformed Amarin (AMRN) over the past year, gaining 16.7% versus a loss of 37.6%. Amarin is the larger company by market cap ($253.9 million vs $241.0 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | AMRN | CAMP |
|---|---|---|
| Share price | $12.02 | $3.84 |
| Market cap | $253.90M | $240.97M |
| 1-day change | -0.41% | -3.03% |
| YTD return | -13.90% | -37.36% |
| 1-year return | -37.62% | +16.72% |
| 5-year return | -88.35% | — |
| Forward P/E | 12.27 | — |
| EPS (TTM) | $-1.20 | $-2.32 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $20.90 | $7.75 |
| 52-week low | $11.83 | $2.86 |
| Distance from 52-week high | -42.49% | -50.45% |
| Average volume | 66.03K | 279.95K |
| Shares outstanding | 21.12M | 62.75M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- CAMP has outperformed AMRN by 54.3 percentage points over the past year.
AMRN vs CAMP FAQ
Which is bigger, Amarin or CAMP4 Therapeutics?
Amarin (AMRN) is larger, with a market capitalization of $253.90M compared with $240.97M for CAMP4 Therapeutics (CAMP).
Which stock has performed better over the past year, AMRN or CAMP?
CAMP returned +16.72% over the past 12 months, compared with -37.62% for AMRN (price return, excluding dividends). Past performance does not predict future results.
Are Amarin and CAMP4 Therapeutics in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.